Rewriting the story: can a talking therapy help people shed self-stigma and reclaim their identity?

NCT ID NCT07735481

First seen Jul 30, 2026 · Last updated Aug 06, 2026 · Updated 3 times

Summary

This trial tests whether Narrative Enhancement and Cognitive Therapy (NECT), a 12-session group program, can help adults with severe mental health disorders — including substance use disorders — overcome self-stigma and promote personal recovery. About 106 participants receiving outpatient psychiatric care will be randomly assigned to either NECT plus usual care or a comparison group that does not target self-stigma. The study measures changes in recovery, self-stigma, and empowerment after the intervention and at follow-up.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Narrative Enhancement Cognitive Therapy (NECT) — a structured group intervention combining psychoeducation, cognitive restructuring, and narrative exercises
What this could lead to
If it works, NECT could offer a practical, low-cost group therapy to help people with mental health disorders reduce self-stigma and improve personal recovery.
What could go wrong
This is a relatively small trial (106 participants) testing a behavioral intervention, so results may not generalize widely. The therapy requires weekly sessions for 12 weeks, and benefits may not persist long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MENTAL DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Geneva University Hospital

    Geneva, Canton of Geneva, 1205, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.